HCA Healthcare, Inc.
Close on Nov 2, 2026Market cap $101.26BP/E 15.5Yield 0.62%
HCA Healthcare Outpatient Dialysis & Lab Peers by Year
Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M)
HCA Healthcare Outpatient Dialysis & Lab Peers: $13,643M in FY2025, up 6.5% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: DaVita Inc. SEC 10-K (XBRL) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,643 | +6.5% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2024 | Dec 31, 2024 | 12,816 | +5.6% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2023 | Dec 31, 2023 | 12,140 | +4.6% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2022 | Dec 31, 2022 | 11,610 | -0.1% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2021 | Dec 31, 2021 | 11,619 | +0.6% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2020 | Dec 31, 2020 | 11,551 | +1.4% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2019 | Dec 31, 2019 | 11,388 | -0.1% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2018 | Dec 31, 2018 | 11,405 | +4.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2017 | Dec 31, 2017 | 10,877 | +1.6% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| FY2016 | Dec 31, 2016 | 10,707 | – | DaVita Inc. SEC 10-K (XBRL) ↗ |
Breakdown
What makes up outpatient Dialysis & Lab Peers
Cite this data
StockData. (2026). HCA Healthcare Outpatient Dialysis & Lab Peers ($M), annual FY2016–FY2025 [Data set]. Compiled from HCA Healthcare SEC filings and investor materials. https://stockdatahq.com/stocks/hca/kpis/peer-dva-rev
See every metric in the HCA Healthcare KPI table. Data updated Oct 29, 2026.